Download full-text PDF |
Source |
|---|
Publication Analysis
Top Keywords
Similar Publications
Impact of Shift Work and Job Category on Lifestyle Factors and Readiness to Change Among Hospital Workers: A Case-Control Study.
Cureus
October 2024
Department of Physiology, All India Institute of Medical Sciences Nagpur, Nagpur, IND.
Background: Shift work is essential in health care because of the need for 24-hour services but it is associated with adverse health outcomes, including disrupted circadian rhythms, poor sleep, unhealthy dietary habits, and increased stress. These effects may differ across job categories, such as nursing officers and hospital support staff, owing to varying physical and psychological demands. Limited research exists on how shift work impacts these groups differently, particularly regarding readiness to change unhealthy lifestyle behaviors.
View Article and Find Full Text PDFArticle Synopsis
- Updated data on chronic respiratory diseases (CRDs) are essential for preventing and controlling these conditions as part of achieving the UN's goal of reducing premature mortality from non-communicable diseases by 2030.
- From 1990 to 2019, global, regional, and national estimates were analyzed for various CRDs, including COPD and asthma, to assess their impact on mortality, disability, and overall prevalence.
- In 2019, CRDs resulted in 4 million deaths and 454.6 million cases worldwide, with conditions like COPD being the leading cause of death among CRDs, despite a decline in age-standardized rates for most diseases over the period analyzed.
Pharmacologic therapy among patients with type 2 diabetes mellitus admitted to the cardiology service.
N Z Med J
March 2023
Green Lane Cardiovascular Service, Auckland City Hospital, 2 Park Road, Auckland.
Aim: To review the management of diabetes control in patients with type 2 diabetes admitted to the cardiology service at Auckland City Hospital for over 48 hours; to assess how many would potentially benefit from introduction of empagliflozin under current Pharmac guidelines.
Methods: A retrospective audit of all admissions into cardiology between 1 November 2020 and 31 January 2021 prior to the availability of empagliflozin. Data collected included diagnosis and presence of type 2 diabetes, HbA1c and diabetes medications.
New Zealand may finally get funded access to diabetes drugs which reduce cardiovascular events and progression of kidney disease: an audit of proposed PHARMAC criteria compared with international guidelines.
N Z Med J
October 2020
Department of Medicine, University of Otago, Wellington.
Aims: Sodium-glucose cotransporter-2 (SGLT-2) inhibitors and glucagon-like peptide-1 (GLP-1) agonists are classes of medications shown to reduce cardiovascular events and slow decline in renal function in people with type 2 diabetes (T2DM). They are recommended for many people as second-line agents after metformin by the American Diabetes Association (ADA) and European Association for the Study of Diabetes (EASD). PHARMAC have proposed criteria for funding in New Zealand.
View Article and Find Full Text PDFThe impact of a point-of-care testing device on CVD risk assessment completion in New Zealand primary-care practice: A cluster randomised controlled trial and qualitative investigation.
PLoS One
April 2017
National Institute for Health Innovation, School of Population Health, University of Auckland, Auckland, New Zealand.
Objectives: To assess the effect of a point of care (POC) device for testing lipids and HbA1c in addition to testing by community laboratory facilities (usual practice) on the completion of cardiovascular disease (CVD) risk assessments in general practice.
Methods: We conducted a pragmatic, cluster randomised controlled trial in 20 New Zealand general practices stratified by size and rurality and randomised to POC device plus usual practice or usual practice alone (controls). Patients aged 35-79 years were eligible if they met national guideline criteria for CVD risk assessment.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!